Aerobic versus resistance training and immune biomarkers in mild-to-moderate COVID 19: a randomized trial
摘要
A new coronavirus emerged in late 2019 and spread rapidly around the globe, leading the World Health Organization to declare COVID-19 a pandemic. Vaccines were developed that helped to reduce severe outcomes, but ongoing variants highlight the need for complementary methods to decrease morbidity and mortality.
ObjectiveTo explore and compare the effect of aerobic versus resistance training on immune system markers, COVID-19 severity, and disease progression during COVID-19 infection.
DesignRandomized study.
ParticipantsThe study included 38 participants with mild–moderate COVID-19, aged 24–45 years. Participants were randomly assigned to two groups: an aerobic exercise group and a resistance training group. The dependent variables were immune biomarkers and respiratory symptom severity.
InterventionsThe interventions comprised moderate-intensity anaerobic or aerobic exercise for 2 weeks (40 min/session, 3 sessions/week).
ResultsThere were no significant differences in immune biomarkers and respiratory symptom severity between the groups (p > 0.05). The severity of respiratory symptoms decreased significantly in the aerobic exercise group after 2 weeks of exercise, while immune biomarkers increased significantly in the aerobic exercise group after 2 weeks of exercise (p < 0.05).
ConclusionThe current study found that 2 weeks of moderate-intensity aerobic exercise was more effective in mitigating the severity and progression of COVID-19 symptoms, potentially increasing immune function.